Biopsy of the submandibular gland could confirm the presence of Parkinson’s disease (PD) in living patients with clinical symptoms, research suggests.
Some pesticides may contribute to Parkinson’s disease risk by inhibiting neuronal aldehyde dehydrogenase activity, a study suggests.
The contribution of neurocognition and negative symptoms to impaired social and role functioning in patients at clinical high risk of psychosis is important enough to warrant targeting both with therapeutic interventions, say researchers.
The majority of parents with bipolar disorder monitor their children's moods, which helps them feel in control of their child's wellbeing, show US study results.
Patients with Parkinson’s disease, particularly those with excessive daytime sleepiness, have reduced melatonin levels and amplitude of the melatonin circadian rhythm, research shows.
Researchers have found that some individuals with bipolar disorder or schizophrenia have combined stress response and immune dysfunctions.
Collaborative care delivered by community health workers can improve outcomes among patients with schizophrenia receiving facility-based case in resource-poor settings, shows a study in The Lancet.
Russian study data bolster the existing body of evidence showing that bipolar disorder is often misdiagnosed as depression.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Study findings confirm the increased risk of death from physical diseases among patients with schizophrenia, and reveal cancer mortality as an issue among middle-aged patients.